These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 25059841

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhanced expression of podoplanin in ameloblastomas.
    González-Alva P, Tanaka A, Oku Y, Miyazaki Y, Okamoto E, Fujinami M, Yoshida N, Kikuchi K, Ide F, Sakashita H, Kusama K.
    J Oral Pathol Med; 2010 Jan; 39(1):103-9. PubMed ID: 19691459
    [Abstract] [Full Text] [Related]

  • 3. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M, Lee HK, Kang YK.
    Anticancer Res; 2003 Jan; 23(2B):1581-8. PubMed ID: 12820426
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential expression of transcription factors Snail, Slug, SIP1, and Twist in ameloblastoma.
    Siar CH, Ng KH.
    J Oral Pathol Med; 2014 Jan; 43(1):45-52. PubMed ID: 23560539
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.
    Ramasami S, Kerr KM, Chapman AD, King G, Cockburn JS, Jeffrey RR.
    J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epithelial-to-mesenchymal transition in ameloblastoma: focus on morphologically evident mesenchymal phenotypic transition.
    Siar CH, Ng KH.
    Pathology; 2019 Aug; 51(5):494-501. PubMed ID: 31262562
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.
    Rosado P, Lequerica-Fernández P, Fernández S, Allonca E, Villallaín L, de Vicente JC.
    Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
    Voutilainen KA, Anttila MA, Sillanpää SM, Ropponen KM, Saarikoski SV, Juhola MT, Kosma VM.
    J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
    [Abstract] [Full Text] [Related]

  • 18. Expression of osteopontin and its receptors in ameloblastomas.
    Wang YP, Liu BY.
    Oral Oncol; 2009 Jun; 45(6):538-42. PubMed ID: 18804406
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.